Jordi Naval
Fondateur chez Aelix Therapeutics SL
Profil
Jordi Naval founded Infociencia SL in 1998 and served as its Chief Executive Officer until 2008.
He also founded Anaxomics Biotech SL in 2007.
Dr. Naval is also the founder of Aelix Therapeutics SL.
He was the Chief Executive Officer of Hervolution ApS from 2021 to 2023.
Naval worked as the Managing Director-Southern Europe at ReSearch Pharmaceutical Services LLC.
Naval received his undergraduate degree from the University of Barcelona and his graduate degree from Universitat Autònoma de Barcelona.
Postes actifs de Jordi Naval
| Sociétés | Poste | Début |
|---|---|---|
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Fondateur | - |
Anciens postes connus de Jordi Naval
| Sociétés | Poste | Fin |
|---|---|---|
Inprother ApS
 Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | Directeur Général | 19/12/2023 |
Infociencia SL
 Infociencia SL Miscellaneous Commercial ServicesCommercial Services Infociencia develops projects for clinical investigation, including clinical and epidemiologic trials, studies, and surveys. The firm was founded in 1998, and is based in Barcelona. | Fondateur | 01/01/2008 |
ReSearch Pharmaceutical Services LLC
 ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA. | Corporate Officer/Principal | - |
Anaxomics Biotech SL
 Anaxomics Biotech SL Pharmaceuticals: MajorHealth Technology Anaxomics Biotech SL discovers and develops pharmaceutical products. Its products and services include discovery and preclinical development, academic research centers, solutions for VCs and investors, clinical development, nutraceutical and cosmetics, and SIMScells. The company was founded by Jose Manuel Mas and Jordi Naval in 2007 and is headquartered in Barcelona, Spain. | Directeur Général | - |
Formation de Jordi Naval
| University of Barcelona | Undergraduate Degree |
| Universitat Autònoma de Barcelona | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ReSearch Pharmaceutical Services LLC
ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA. | Commercial Services |
Infociencia SL
Infociencia SL Miscellaneous Commercial ServicesCommercial Services Infociencia develops projects for clinical investigation, including clinical and epidemiologic trials, studies, and surveys. The firm was founded in 1998, and is based in Barcelona. | Commercial Services |
Anaxomics Biotech SL
Anaxomics Biotech SL Pharmaceuticals: MajorHealth Technology Anaxomics Biotech SL discovers and develops pharmaceutical products. Its products and services include discovery and preclinical development, academic research centers, solutions for VCs and investors, clinical development, nutraceutical and cosmetics, and SIMScells. The company was founded by Jose Manuel Mas and Jordi Naval in 2007 and is headquartered in Barcelona, Spain. | Health Technology |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Health Technology |
Inprother ApS
Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | Health Technology |
